Core Laboratories Inc. (CLB) stock
CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/300% above fair value
$8.39−0.06 (-0.71%)
Close on Nov 17, 2026Market cap $384.46MP/E 24.7Yield 0.48%
Core Laboratories operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Core Laboratories's operating cash flow for the twelve months ending Sep 30, 2026 was $24.69M, down 50.3% year over year. For fiscal 2025 it was $37.03M, down 34.3% from the year before. The highest annual figure on record is $56.39M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.03M | -34.3% |
| FY2024 | Dec 31, 2024 | $56.39M | +127.5% |
| FY2023 | Dec 31, 2023 | $24.79M | -0.7% |
| FY2022 | Dec 31, 2022 | $24.96M | -31.8% |
| FY2021 | Dec 31, 2021 | $36.58M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.97M | -41.6% |
| Q2 FY2026 | Jun 30, 2026 | $7.81M | -43.9% |
| Q1 FY2026 | Mar 31, 2026 | $3.97M | -40.5% |
| Q4 FY2025 | Dec 31, 2025 | $7.95M | -61.5% |
| Q3 FY2025 | Sep 30, 2025 | $8.50M | -35.1% |
| Q2 FY2025 | Jun 30, 2025 | $13.92M | -18.8% |
| Q1 FY2025 | Mar 31, 2025 | $6.66M | +20.4% |
| Q4 FY2024 | Dec 31, 2024 | $20.62M | +6.1% |
| Q3 FY2024 | Sep 30, 2024 | $13.10M | – |
| Q2 FY2024 | Jun 30, 2024 | $17.15M | +96.2% |
| Q1 FY2024 | Mar 31, 2024 | $5.53M | – |
| Q4 FY2023 | Dec 31, 2023 | $19.43M | +47.1% |
| Q3 FY2023 | Sep 30, 2023 | -$212.00K | -103.6% |
| Q2 FY2023 | Jun 30, 2023 | $8.74M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.17M | – |
| Q4 FY2022 | Dec 31, 2022 | $13.21M | – |
| Q3 FY2022 | Sep 30, 2022 | $5.85M | – |
See a number that looks wrong?